Market Overview

Radient Pharmaceuticals Announces 1:25 Reverse Stock Split

Radient Pharmaceuticals Corporation (RXPC) announced Tuesday that its Board of Directors has authorized the implementation of a 1:25 reverse split of the Company's outstanding common shares, which will be completed on or before January 15, 2012 .

Posted-In: News Small Cap Stock Split After-Hours Center

 

Related Articles (RXPC)

Around the Web, We're Loving...

Get Benzinga's Newsletters